GLP-1 medications , or glucagon-like peptide-1 receptor agonists , represent a truly innovation in how we handle type 2 diabetes . These new medications work by mimicking the body’s inherent GLP-1 process, https://socialwebnotes.com/story6896408/glp-1-a-revolutionary-approach-in-glucose-care